Rizvi Syed Ali-aamir bought RCKT
February 11, 2026 · Form 4 insider transaction
Rizvi Syed Ali-aamir bought 93,037 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
93,037
Price
$0.00
Total value
N/A
InsiderRizvi Syed Ali-aamir
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after93,037
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase a total of 93,037 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.